Migraine patients report reduced attack frequency and intensity in observational studies, and inhaled cannabis shows acute pain reduction in some trials. Evidence quality is moderate; overuse can cause rebound headaches just as conventional acute medications can.
If migraines are your qualifying complaint, document frequency, prior treatments (triptans, preventives), and disability impact — this is what certifying physicians and stricter state programs look for.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law.